High Complete Response Rate with TNB-486 in Relapsed/refractory Follicular Lymphoma: Interim Results from an Ongoing Phase 1 Study.
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
T Cell Therapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)